DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2020年11月08日 (日) 午前 9:30 - 2020年11月10日 (火) 午後 5:40

Tokyo, 103-00 Japan

17th DIA Japan Annual Meeting 2020

Beyond Innovation

OS06 Challenge of Incorporating Patient Perspective in Drug Development: Lessons Learned from “System of Patient Engagement inRregulatory Review” by US Food and Drug Administration/European Medicines Agency

Session Chair(s)

Junko  Sato, PhD

Junko Sato, PhD

Associate Executive Director

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Nanae  Tanemura, PhD

Nanae Tanemura, PhD

Department of Food Function and Labeling·Head of section

National Institutes of Biomedical Innovation, Health and Nutrition, Japan

Speaker(s)

Junko  Sato, PhD

Junko Sato, PhD

Junko Sato, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Associate Executive Director

Kyoko  Asai, DVM, PhD

Kyoko Asai, DVM, PhD

Kyoko Asai, DVM, PhD

Hypersomnia & Long Sleeper Support Organization in Japan, Japan

Representative Director & CEO

Yukiko  Nishimura, PhD, MSc

Yukiko Nishimura, PhD, MSc

Yukiko Nishimura, PhD, MSc

NPO ASrid, Japan

President

Juan  Garcia-Burgos, MD, PhD

Juan Garcia-Burgos, MD, PhD

Juan Garcia-Burgos, MD, PhD

European Medicines Agency, Netherlands

Head of Public and Stakeholders Engagement Department

Theresa  Mullin, PhD

Theresa Mullin, PhD

Theresa Mullin, PhD

FDA, United States

Associate Center Director - Strategic Initiatives, CDER

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。